Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -22.0% | -10.9% | -13.3% | -32.7% | +32.9% | +24.9% | +12.7% | -36.2% | +241.4% | +56.2% | +409.4% | – | |
| – | -9.4% | +67.0% | -26.9% | -45.9% | -0.5% | +15.9% | +21.4% | +9.6% | -13.0% | +41.5% | +50.3% | – | |
| – | -325.7% | – | – | – | – | – | -471.4% | – | – | +69.0% | +668.6% | – | |
| – | -2.5% | +12.2% | +9.7% | +10.1% | -27.5% | +3.4% | -13.6% | +13.1% | +5.0% | -44.7% | -20.3% | – | |
| – | -1.3% | +11.6% | -1.1% | +1.5% | -4.6% | +11.8% | +12.4% | +30.5% | +48.7% | -26.5% | +19.3% | – | |
| – | -1.9% | +6.1% | +7.0% | +156.5% | -65.0% | +34.6% | -21.1% | +38.0% | +16.0% | -32.5% | +8.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.3% | +600.0% | -71.4% | +0.0% | +0.0% | +200.0% | -83.3% | -100.0% | – | +228.6% | -1.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -825.0% | – | – | +5,966,566.7% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.